Basics NewAmsterdam Pharma Company IPO Date: February 9, 2021 Sector: Healthcare Industry: Biotech Market Cap: $4B Activated in VL: True Average Daily Range Avg Daily Range: $0.49 | 2.76% Avg Daily Range (30 D): $1.10 | 2.95% Avg Daily Range (90 D): $0.92 | 2.93% Institutional Daily Volume Avg Daily Volume: .39M Avg Daily Volume (30 D): .92M Avg Daily Volume (90 D): .93M Trade Size Avg Trade Size (Sh.): 90 Avg Trade Size (Sh.) (30 D): 69 Avg Trade Size (Sh.) (90 D): 77 Institutional Trades Total Inst.Trades: 901 Avg Inst. Trade: $1.53M Avg Inst. Trade (30 D): $1.5M Avg Inst. Trade (90 D): $1.69M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $1.54M Avg Closing Trade (30 D): $2.39M Avg Closing Trade (90 D): $2.04M Avg Closing Volume: 61.58K     News Aug 7, 2025 @ 12:21 AM NewAmsterdam (NAMS) Q2 Revenue Jumps 49% Source: Jesterai Jun 9, 2025 @ 11:00 AM NewAmsterdam Pharma Announces Positive Topline Alz... Source: N/A Jan 9, 2025 @ 8:38 PM NewAmsterdam Pharma Reports Inducement Grants Unde... Source: N/A Dec 13, 2024 @ 10:16 PM NewAmsterdam Pharma Announces Closing of Upsized $... Source: N/A Dec 12, 2024 @ 2:37 AM NewAmsterdam Pharma Announces Pricing of Upsized $... Source: N/A Financials   TTM Q3 2025 Q2 2025 Basic EPS $-2.04 $-.61 $-.15 Diluted EPS $-2.04 $-.61 $-.15 Revenue $ 35.24M $ .35M $ 19.15M Gross Profit $ $ $ Net Income / Loss $ -221.07M $ -72.01M $ -17.36M Operating Income / Loss $ -202.93M $ -55.14M $ -35.64M Cost of Revenue $ $ $ Net Cash Flow $ 112.1M $ -24.37M $ -193.38M PE Ratio